SOPH rose +3.84% to close at $8.65 in the latest completed session, up +$0.32 from the prior close of $8.33. The move occurred during regular market hours, extending a rally that carried shares to a fresh 52-week high (intraday high $8.68).

MTW shares rose roughly 37% over the last 30 days, climbing from $14.37 to $19.68, driven primarily by a stronger-than-expected second-quarter 2026 earnings report. Adjusted EPS of $0.46 significantly exceeded the $0.11 consensus estimate, while net sales rose 10% year over year to $595 million.

CTNM rose +7.30% in the latest regular session, closing at $17.19 (from a $16.02 prior close) and touching a new 52-week high of $17.35. The rally extended a multi-week uptrend tied to lead asset PIPE-791 (LPA1 antagonist), now in the global Phase 2 PROPEL-IPF trial for idiopathic pulmonary fibrosis.

SGMT shares climbed roughly 45% over the last 30 days, from a closing price near $7.07 in late July to $10.25 by the August 21 close. The move extends a broader rally, with the stock up more than 40% over the trailing quarter and roughly 73% year to date.

Mistras Group (MG) shares climbed roughly 21% over the trailing 30 days, rising from about $15.64 to $18.96 on the back of strong second-quarter results. The rally was driven by better-than-expected Q2 2026 earnings, record adjusted EBITDA, and raised full-year guidance.

Delcath Systems (DCTH) climbed roughly 40% over the past 30 days, rising from about $12.22 to $17.14. The rally was driven by stronger-than-expected second-quarter 2026 results, reported before the open on August 6, 2026.

SPIR closed up +0.36% to $13.94 during Friday's regular session, a modest gain from the prior close of $13.89. The move was low-conviction: shares opened higher at $14.16 but faded through a $13.69–$14.40 range on light volume (about 432K vs. roughly 1.1M average).

Entera Bio (ENTX) shares climbed roughly 59% over the trailing 30 days, rising from about $2.03 on July 22 to $3.23 as of the most recent close. The move was driven primarily by U.S. FDA alignment on a single registrational Phase 3 trial for its lead candidate EB613 and a $275 million private placement completed in July 2026.

SMCI shares climbed roughly 21.9% over the 30-day period, rising from a close of $30.56 to a latest close near $37.24. The move was driven by a sharp recovery in gross margin, record new orders of more than $60 billion, and fiscal 2027 revenue guidance well above Wall Street expectations.

Selected target: $60 per share, roughly 60% above recent trading near $37 and just below the 52-week high of about $62. Bull case: a reported $60 billion order book, surging AI-server demand, close ties to Nvidia, and recovering gross margins.

Sezzle (SEZL) shares fell roughly 31.6% over the trailing 30 days, declining from about $174.24 to $119.11. The decline was triggered by Sezzle's second-quarter 2026 report, which beat estimates and raised full-year guidance but flagged slowing second-half growth.

TTM Technologies shares closed at $110.54 on August 21, 2026, down roughly 24% over the prior 30 days from $144.70 on July 22, 2026. The decline occurred despite record second-quarter results, including revenue of $1.0 billion (up 37% year over year) and non-GAAP earnings of $0.99 per share, with raised full-year guidance.

Sterling Infrastructure (STRL) declined roughly -28% over the last 30 days, falling from about $719 on July 22 to a closing price of $516.81 on August 21, 2026. The pullback followed an extraordinary rally that pushed shares to a 52-week intraday high of $1,005.68 in early June before sentiment reversed.

Hut 8 shares fell roughly 26% over the last 30 days, from about $109.86 at the July 22 close to $80.86 at the August 21 close. The decline was driven by a second-quarter earnings miss, a large digital-asset mark-to-market loss tied to Bitcoin's weakness, and profit-taking across AI-pivoting Bitcoin miners.

Core Scientific shares fell roughly 22% over the trailing 30 days, sliding from about $22.75 in late July to a close near $17.81, well below their 52-week high of $30.46. The pullback occurred despite strong top-line growth, as second-quarter 2026 revenue more than doubled year over year to $164.2 million.

The selected price target is $11 per share , the highest current analyst target and a level just above the stock's 52-week high of $10.05. Butterfly Network has delivered record quarterly revenue, raised its full-year guidance, and holds a "Strong Buy" consensus, the strongest bullish factors supporting further upside.

Selected price target: $15 per share, roughly 25% above recent trading levels near $12 and about 17% above the 52-week high of $12.85. Bullish factors: A recovery in the animal-safety business, improving food-safety margins, portfolio simplification through divestitures, and a series of analyst target increases.

SSMR shares climbed about 24.6% over the past 30 days, rising from a closing price of $14.96 on July 22, 2026, to $18.64 by August 21, 2026. The rally has been fueled by rising silver prices, a strengthening industrial and AI-related demand narrative, and encouraging underground drill results at the Sunshine Mine.

Aveanna Healthcare (AVAH) climbed roughly 39% over the trailing 30 days, rising from about $9.45 to above $13. The move was driven primarily by a stronger-than-expected second-quarter report and a raised full-year outlook announced August 13, 2026.

AMPL shares climbed roughly 52% over the past 30 days, rising from a close of $8.74 on July 22 to $13.29 on August 21. The advance extends a broader rally, with the stock more than doubling over the trailing quarter from around $6.50.